Read More 1 minute read Analyst Ratings Downgrades News Wells Fargo Downgrades Signature Bank By Benzinga Newsdesk Today, 11:19 PM Wells Fargo analyst Steven Chercover downgrades Signature Bank (NASDAQ:SBNY) SBNY
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Arhaus, Lowers Price Target to $11 By Benzinga Newsdesk Today, 11:19 PM Morgan Stanley analyst Simeon Gutman maintains Arhaus (NASDAQ:ARHS) with a Equal-Weight and lowers the price target from $12 to $11. ARHS
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Overweight on American Well, Lowers Price Target to $5 By Benzinga Newsdesk Today, 11:19 PM Morgan Stanley analyst Craig Hettenbach maintains American Well (NYSE:AMWL) with a Overweight and lowers the price target from $6 to $5. AMWL
Read More 1 minute read Analyst Ratings Downgrades News Odeon Capital Downgrades KeyCorp to Hold By Benzinga Newsdesk Today, 11:19 PM Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold. KEY
Read More 1 minute read Analyst Ratings News Price Target Goldman Sachs Maintains Neutral on Reliance Steel & Aluminum, Raises Price Target to $270 By Benzinga Newsdesk Today, 11:19 PM Goldman Sachs analyst Kate McShane maintains Reliance Steel & Aluminum (NYSE:RS) with a Neutral and raises the price target from $245 to $270. RS
Read More 1 minute read Analyst Ratings News Price Target Goldman Sachs Maintains Neutral on Invesco, Lowers Price Target to $19 By Benzinga Newsdesk Today, 11:19 PM Goldman Sachs analyst Alexander Blostein maintains Invesco (NYSE:IVZ) with a Neutral and lowers the price target from $20 to $19. IVZ
Read More 1 minute read Analyst Ratings News Price Target Goldman Sachs Maintains Buy on General Electric, Raises Price Target to $96 By Benzinga Newsdesk Today, 11:19 PM Goldman Sachs analyst Joe Ritchie maintains General Electric (NYSE:GE) with a Buy and raises the price target from $84 to $96. GE
Read More 1 minute read Analyst Ratings News Price Target Goldman Sachs Maintains Buy on Fulcrum Therapeutics, Lowers Price Target to $9 By Benzinga Newsdesk Today, 11:19 PM Goldman Sachs analyst Madhu Kumar maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Buy and lowers the price target from $17 to $9. FULC
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on PennantPark Floating Rate, Maintains $12 Price Target By Benzinga Newsdesk Today, 11:19 PM JMP Securities analyst Kevin Fitzsimmons reiterates PennantPark Floating Rate (NYSE:PFLT) with a Market Outperform and maintains $12 price target. PFLT
Read More 1 minute read Analyst Ratings News Price Target Reiteration Wedbush Reiterates Outperform on Cognizant Tech Solns, Maintains $75 Price Target By Benzinga Newsdesk Today, 11:19 PM Wedbush analyst Moshe Katri reiterates Cognizant Tech Solns (NASDAQ:CTSH) with a Outperform and maintains $75 price target. CTSH